PolyModels Hub secures £7M investment led by Molten Ventures and Marathon VC

London-based PolyModels Hub has secured a £7 million Series
A investment from Molten Ventures, in partnership with Marathon VentureCapital.

PolyModels Hub is a biotech software company developing the
digital backbone for biopharma process development, reshaping how medicines are
designed, developed, and manufactured. The company combines AI, advanced
modelling, and data-driven workflows to help teams move faster from lab
experiments to large-scale production.

Its flagship platform, ModelFlow, brings together process
knowledge, models, simulation, and workflow management in a single environment.
Scientists and engineers can design, test, and optimise drug processes more
quickly and efficiently, helping organisations reduce time, cost, and risk
while improving quality and compliance.

According to Antonio Benedetti, Co-founder and CEO of
PolyModels Hub, the pharmaceutical sector is experiencing a major digital shift.
He explains that the company’s technology and team have already demonstrated
significant impact for large pharmaceutical partners within just 18 months,
with these collaborations now expanding globally.

We’re investing deeply in
complex biologics and advancing our platform to empower scientists with the
model-based solutions they deserve to transform molecules into medicines for
the 21st century.

With the latest investment, PolyModels Hub plans to grow
its engineering and product teams, further develop its core platform, and reach
more pharmaceutical companies globally.

The company will prioritise scalable solutions for process
and regulatory workflows, supporting the broader digitalisation of biopharma
process development and contributing to more efficient delivery of new
medicines to patients.